Early election results are showing that ballot measure creating a new role in veterinary medicine is expected to pass.

Are you a print subscriber? Activate your account. By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ...

But by the end of the decade, the company should be on its way to replacing Keytruda as its now sold with a new formulation of the medicine. And Merck's business extends beyond this single product.

Highlights,Merck gains two new EU approvals for KEYTRUDA in gynecologic cancers.,Approvals cover treatments for advanced endometrial and cervical cancers.,Clinical trials show significant benefits in ...

Merck Research Laboratories. “These approvals underscore the continued expansion of the use of KEYTRUDA in diverse patient populations and treatment settings with utility of KEYTRUDA ranging ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the European Commission (EC) has approved two new indications for KEYTRUDA ® (pembrolizumab), Merck ...

Credit: eamesBot via Shutterstock. Alpha-9 Oncology is the latest radiopharma to raise funds, drawing in $175m in Series C financing, to advance its radiopharmaceutical candidates through clinical ...

DAVIDSON, N.C., Oct. 22, 2024 /PRNewswire/ -- Mobile Veterinary Specialists (MOVES), a leading network of over 35 board-certified mobile veterinary specialists operating in 21 states, is excited ...

We are home to the Veterinary Health Innovation Engine (vHive), a research centre, startup and incubator supported by a co-investment of £8.5 million in resources, dedicated to the development and ...